Standing of “Julphar” in Global Pharmaceutical Industry - A Benchmarking report

Authors

  • AyaWadi MBA student Author
  • Robin A. Carvalho MBA student Author

Keywords:

Benchmarking, Financial Analysis, Corporate valuation, Ratio Analysis

Abstract

To meet stakeholder’s interest is the prime requirement of all the corporations. The measurement tools of the firm’s financial health guide the stakeholders to understand company’s performance and evaluate its future prospects in a better way. There are some financial monitoring indicators that evaluate the company’s progress in context of its commitments, funding for operations, projects in hands and future plans against its eligible cost. Financial statements and ratios assist the investors to know better about the financial condition of the company and its overall performance. It is particularly helpful in ascertaining the liquidity risk, credit risk, financial risk and business risk of the firm. This paper will focus on measuring the financial health of Julphar by conducting a benchmarking exercise.

Author Biographies

  • AyaWadi, MBA student

    MBA student, 
    Newyork Institute of Technology, Abudhabi Campus, UAE

  • Robin A. Carvalho, MBA student

    MBA student
    Newyork Institute of Technology, Abudhabi Campus, UAE 

Volume 2 Isse No.3

Downloads

Published

2024-04-27

How to Cite

Standing of “Julphar” in Global Pharmaceutical Industry - A Benchmarking report. (2024). International Academic Research Journal of Economics and Finance, 2(3), 21-40. https://www.acrpub.com/index.php/IARJEF/article/view/75

Similar Articles

11-20 of 27

You may also start an advanced similarity search for this article.